AAAAAA

   
Results: 1-9 |
Results: 9
CORECEPTOR USAGE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 PRIMARY ISOLATES AND BIOLOGICAL CLONES IS BROAD AND DOES NOT CORRELATE WITH THEIR SYNCYTIUM-INDUCING CAPACITIES
Authors: GUILLON C VANDERENDE ME BOERS PHM GRUTERS RA SCHUTTEN M OSTERHAUS ADME
Citation: C. Guillon et al., CORECEPTOR USAGE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 PRIMARY ISOLATES AND BIOLOGICAL CLONES IS BROAD AND DOES NOT CORRELATE WITH THEIR SYNCYTIUM-INDUCING CAPACITIES, Journal of virology, 72(7), 1998, pp. 6260-6263
HIGH-DOSE NEVIRAPINE IN PREVIOUSLY UNTREATED HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PERSONS DOES NOT RESULT IN SUSTAINED SUPPRESSION OF VIRAL REPLICATION
Authors: DEJONG MD VELLA S CARR A BOUCHER CAB IMRIE A FRENCH M HOY J SORICE S PAULUZZI S CHIODO F WEVERLING GJ VANDERENDE ME FRISSEN PJ WEIGEL HM KAUFFMANN RH LANGE JMA YOON R MORONI M HOENDERDOS E LEITZ G COOPER DA HALL D REISS P
Citation: Md. Dejong et al., HIGH-DOSE NEVIRAPINE IN PREVIOUSLY UNTREATED HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PERSONS DOES NOT RESULT IN SUSTAINED SUPPRESSION OF VIRAL REPLICATION, The Journal of infectious diseases, 175(4), 1997, pp. 966-970
PREVALENCE OF PARVOVIRUS B19 INFECTION IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS
Authors: VANELSACKERNIELE AMW KROON FP VANDERENDE ME SALIMANS MMM SPAAN WJM KROES ACM
Citation: Amw. Vanelsackerniele et al., PREVALENCE OF PARVOVIRUS B19 INFECTION IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS, Clinical infectious diseases, 23(6), 1996, pp. 1255-1260
HIV-2 INFECTION IN 12 EUROPEAN RESIDENTS - VIRUS CHARACTERISTICS AND DISEASE PROGRESSION
Authors: VANDERENDE ME SCHUTTEN M LY TD GRUTERS RA OSTERHAUS ADME
Citation: Me. Vanderende et al., HIV-2 INFECTION IN 12 EUROPEAN RESIDENTS - VIRUS CHARACTERISTICS AND DISEASE PROGRESSION, AIDS, 10(14), 1996, pp. 1649-1655
ZIDOVUDINE PLUS INTERFERON-ALPHA VERSUS ZIDOVUDINE ALONE IN HIV-INFECTED SYMPTOMATIC OR ASYMPTOMATIC PERSONS WITH CD4-THAN-150X10(6)( CELL COUNTS GREATER)I - RESULTS OF THE ZIDON TRIAL/
Authors: FERNANDEZCRUZ E LANG JM FRISSEN J FURNER V CHATEAUVERT M BOUCHER CAB DOWD P STEVENS J GOLD J MICHELMORE H BENSON E SPELMAN E HOY J WRIGHT E FRENCH M HUDSON J MALLAL S BODSWORTH N STINGL G MAYERHOFER S KRONAWETTER M TSOUKAS C SZABO T KATLAMA C GUERMONPREZ G RAFFI F BILLAUD E MILPIED B BOURGEOT V FLEISHMANN M BARRIER JH DELZANT G WINTER C MEHARZI J TREPO C COTTE L ROUGIER P HASSAIRI N CHOUTET P BESNIER JM LAFEUILLADE A RASOKAT H GROSS G MAUSCH HE STRATIGOS J POLYDOROV D STAVRIANEAS N KIOSSES V MANDALAKI T KARAFOULIDOU A KARABINIS A STERGIOU G PLOUMIDES G PITSAS A TASSOPOULOS N KOUTSOUNOPOULOS G HATZAKIS A MORONI M DARMINIO A BINI T CHIODO F COLANGELI V RICCHI E AIUTI F FERRARA R MEZZAROMA I LANGE JMA FRISSEN PHJ SPRENGER HG KROON FP VANDERENDE ME DEMARIE S KOOPMANS PP DOLMANS WMV SCHREIJ GS WEIGEL HM TENNAPEL CHH TENKATE RW MARANON G ZABAY JM COSIN J PENA JM RUBIO R RIBERA E VAZQUEZ JMM LEAL M ANDREU J CARTON JA ASENSI V GOMEZTRUJILLO F ORIHUELA F SERRANO C FERRER E MANDAL BK JOHNSON M MCKARTHY K FARMER D TANG A MITCHELL SA BROWN J TOORAWA R YEO J
Citation: E. Fernandezcruz et al., ZIDOVUDINE PLUS INTERFERON-ALPHA VERSUS ZIDOVUDINE ALONE IN HIV-INFECTED SYMPTOMATIC OR ASYMPTOMATIC PERSONS WITH CD4-THAN-150X10(6)( CELL COUNTS GREATER)I - RESULTS OF THE ZIDON TRIAL/, AIDS, 9(9), 1995, pp. 1025-1035
CRYPTOCOCCAL MENINGITIS IN HIV-INFECTED PATIENTS
Authors: LEENDERS AC VANDERENDE ME VANDERREE TC DEMARIE S
Citation: Ac. Leenders et al., CRYPTOCOCCAL MENINGITIS IN HIV-INFECTED PATIENTS, AIDS, 8(12), 1994, pp. 1741-1743
ZIDOVUDINE AND INTERFERON-ALPHA, COMBINATION THERAPY VERSUS ZIDOVUDINE MONOTHERAPY IN SUBJECTS WITH SYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
Authors: FRISSEN PHJ VANDERENDE ME TENNAPEL CHH WEIGEL HM SCHREIJ GS KAUFFMANN RH KOOPMANS PP HOEPELMAN AIM DEBOER JB WEVERLING GJ HAVERKAMP G DOWD P MIEDEMA F SCHUURMAN R BOUCHER CAB LANGE JMA
Citation: Phj. Frissen et al., ZIDOVUDINE AND INTERFERON-ALPHA, COMBINATION THERAPY VERSUS ZIDOVUDINE MONOTHERAPY IN SUBJECTS WITH SYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION, The Journal of infectious diseases, 169(6), 1994, pp. 1351-1355
BODY-COMPOSITION IN PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME - A VALIDATION-STUDY OF BIOELECTRIC IMPEDANCE ANALYSIS
Authors: SLUYS TEMS VANDERENDE ME SWART GR VANDENBERG JWO WILSON JHP
Citation: Tems. Sluys et al., BODY-COMPOSITION IN PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME - A VALIDATION-STUDY OF BIOELECTRIC IMPEDANCE ANALYSIS, JPEN. Journal of parenteral and enteral nutrition, 17(5), 1993, pp. 404-406
THE CONCORDE TRIAL
Authors: DANNER SA SCHATTENKERK JKME LOELIGER AE VANDERMEER JTM REISS P HENRICHS JM FRISSEN PHJ WEIGEL HM MULDER JW MEENHORST PL VANDERWOLF MGB TENVEEN JH CLAESSEN FAP VEENSTRA J BORLEFFS JCC HOEPELMAN IM SCHNEIDER ME DEMARIE S VANDERENDE ME VOETS W KAUFFMANN RH KROON FP JUTTMAN JR FOLMER SCCR FERWERDA J TENKATE RW VANLEUSEN R VREDEN SGS PERENBOOM R SPRENGER HG TENNAPEL CHH
Citation: Sa. Danner et al., THE CONCORDE TRIAL, Lancet, 341(8855), 1993, pp. 1276-1276
Risultati: 1-9 |